ABSENCE OF FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100 IN FINNISH PATIENTS WITH ELEVATED SERUM-CHOLESTEROL

被引:60
|
作者
HAMALAINEN, T
PALOTIE, A
AALTOSETALA, K
KONTULA, K
TIKKANEN, MJ
机构
[1] UNIV HELSINKI,DEPT MED 3,SF-00290 HELSINKI 29,FINLAND
[2] UNIV HELSINKI,DEPT CLIN CHEM,SF-00290 HELSINKI 29,FINLAND
[3] UNIV HELSINKI,RECOMBINANT DNA LAB,SF-00290 HELSINKI 29,FINLAND
关键词
Apolipoprotein B-100; Atherosclerosis; Hypercholesterolemia;
D O I
10.1016/0021-9150(90)90038-K
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial defective apolipoprotein B-100 is a genetic disorder which is associated with elevated plasma LDL levels. It appears to result from a G → A mutation at nucleotide 10 708 in exon 26 of the apolipoprotein B-100 gene leading to a substitution of glutamine for arginine at amino acid residue 3500. We explored the possible role of this point mutation as a cause of elevated plasma cholesterol among the Finns, a genetically isolated population in which both hypercholesterolemia and coronary heart disease are common: 552 hyperlipidemic patients from Western and Southern Finland were screened either by assaying patient sera with monoclonal antibody MB47 or by amplifying the region of the apo B gene containing the nucleotide 10 708 followed by hybridization of the amplified DNA with allele-specific oligonucleotide probes. Not a single individual with this particular mutation could be found. We conclude that familial defective apo B-100 is not a common cause of elevated plasma cholesterol in this population. © 1990.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 50 条
  • [1] CHOLESTEROL-LOWERING TREATMENT IN PATIENTS WITH FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    GEISEL, J
    SCHLEIFENBAUM, T
    OETTE, K
    [J]. MEDIZINISCHE WELT, 1992, 43 (11): : 946 - 950
  • [2] CHOLESTEROL-LOWERING DRUGS IN FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    MAHER, VMG
    GALLAGHER, JJ
    THOMPSON, GR
    MYANT, NB
    [J]. LANCET, 1992, 339 (8796): : 811 - 811
  • [3] RESPONSE TO CHOLESTEROL-LOWERING DRUGS IN FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    MAHER, VMG
    GALLAGHER, JJ
    THOMPSON, GR
    MYANT, NB
    [J]. ATHEROSCLEROSIS, 1991, 91 (1-2) : 73 - 76
  • [4] HYPOCHOLESTEROLEMIC EFFECTS OF LOVASTATIN IN FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    ILLINGWORTH, DR
    VAKAR, F
    MAHLEY, RW
    WEISGRABER, KH
    [J]. LANCET, 1992, 339 (8793): : 598 - 600
  • [5] HYPOCHOLESTEROLEMIC EFFECTS OF CHOLESTYRAMINE AND COLESTIPOL IN PATIENTS WITH FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    SCHMIDT, EB
    ILLINGWORTH, DR
    BACON, S
    MAHLEY, RW
    WEISGRABER, KH
    [J]. ATHEROSCLEROSIS, 1993, 98 (02) : 213 - 217
  • [6] FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100 - A MUTATION OF APOLIPOPROTEIN-B THAT CAUSES HYPERCHOLESTEROLEMIA
    INNERARITY, TL
    MAHLEY, RW
    WEISGRABER, KH
    BERSOT, TP
    KRAUSS, RM
    VEGA, GL
    GRUNDY, SM
    FRIEDL, W
    DAVIGNON, J
    MCCARTHY, BJ
    [J]. JOURNAL OF LIPID RESEARCH, 1990, 31 (08) : 1337 - 1349
  • [7] FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100 - A COMMON CAUSE OF PRIMARY HYPERCHOLESTEROLEMIA
    RAUH, G
    KELLER, C
    SCHUSTER, H
    WOLFRAM, G
    ZOLLNER, N
    [J]. CLINICAL INVESTIGATOR, 1992, 70 (01): : 77 - 84
  • [8] HYPOLIPIDEMIC EFFECTS OF NICOTINIC-ACID IN PATIENTS WITH FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    SCHMIDT, EB
    ILLINGWORTH, DR
    BACON, S
    RUSSELL, SJ
    THATCHER, SR
    MAHLEY, RW
    WEISGRABER, KH
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (02): : 137 - 139
  • [9] A ROBUST STRATEGY FOR SCREENING AND CONFIRMATION OF FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    MAMOTTE, CDS
    VANBOCKXMEER, FM
    [J]. CLINICAL CHEMISTRY, 1993, 39 (01) : 118 - 121
  • [10] ASSOCIATION BETWEEN A SPECIFIC APOLIPOPROTEIN-B MUTATION AND FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    SORIA, LF
    LUDWIG, EH
    CLARKE, HRG
    VEGA, GL
    GRUNDY, SM
    MCCARTHY, BJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (02) : 587 - 591